Colforsin-induced vasodilation in chronic hypoxic pulmonary hypertension in rats-Reference-Cited by-同舟云学术

Colforsin-induced vasodilation in chronic hypoxic pulmonary hypertension in rats

Published:2010-03-19 Issue:3 Volume:24 Page:432-440
ISSN:0913-8668
Container-title:Journal of Anesthesia
language:en
Short-container-title:J Anesth

Author:

Yokochi Ayumu,Itoh Hiroo,Maruyama Junko,Zhang Erquan,Jiang Baohua,Mitani Yoshihide,Hamada Chikuma,Maruyama Kazuo

Publisher

Springer Science and Business Media LLC

Subject

Anesthesiology and Pain Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00540-010-0912-7.pdf

Reference37 articles.

1. Cogolludo A, Moreno L, Villamor E. Mechanisms controlling vascular tone in pulmonary arterial hypertension: implication for vasodilator therapy. Pharmacology. 2007;79:65–75.

2. Fullerton DA, Agrafojo J, McIntyre RC. Pulmonary vascular smooth muscle relaxation by cAMP-mediated pathways. J Surg Res. 1996;61:444–8.

3. Rabinovitch M, Keane JF, Norwood WI. Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects. Circulation. 1984;69:655–67.

4. Maruyama J, Maruyama K. Impaired nitric oxide-dependent responses and their recovery in hypertensive pulmonary arteries of rats. Am J Physiol. 1994;266:H2476–88.

5. Fried R, Reid L. The effect of isoproterenol on the development and recovery of hypoxic pulmonary hypertension. Am J Pathol. 1985;121:102–11.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adenylyl cyclase isoforms 5 and 6 in the cardiovascular system: complex regulation and divergent roles;Frontiers in Pharmacology;2024-04-03

2. Right sided heart failure and pulmonary hypertension: New insights into disease mechanisms and treatment modalities;Progress in Pediatric Cardiology;2016-12

3. Novel investigational therapies for treating pulmonary arterial hypertension;Expert Opinion on Investigational Drugs;2015-10-20

4. Pulmonary Hypertension: Novel Pathways and Emerging Therapies Inhibitors of cGMP and cAMP Metabolism;HANDB EXP PHARMACOL;2013

5. Pulmonary Hypertension: Novel Pathways and Emerging Therapies Inhibitors of cGMP and cAMP Metabolism;Handbook of Experimental Pharmacology;2013